Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × HER-2 Positive Breast Cancer × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 74 Breast Neoplasms 20 Insulin Resistance 17 Prostatic Neoplasms 10 Obesity 10 Pancreatic Neoplasms 8 Endometrial Neoplasms 7 Anovulation 6 Neoplasms 5 Neoplasm Metastasis 5 Infertility 5 Colorectal Neoplasms 4 Weight Loss 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lung Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hyperandrogenism 3 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Metabolic Syndrome 2 Menstruation Disturbances 2 Lymphoma, Large B-Cell, Diffuse 2 Kidney Neoplasms 2 Inflammation 2

Interventions

liposomal doxorubicin 1 Trastuzumab 1 Metformin 1 Doxorubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02488564 2025-02-03

met-HEReMYTA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Completed

HER-2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡